Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2008-09-05
2010-11-23
Meller, Michael V (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
07838047
ABSTRACT:
The present invention relates to a pharmaceutical composition and health food comprisingPhellinussp. PL3 extract or phellinsin A isolated from the same as an effective component. More particularly, the present invention relates to a pharmaceutical composition and health food comprisingPhellinussp. PL3 extract or phellinsin A isolated from the same as an effective component, wherein thePhellinussp. PL3 extract and its phellinsin A inhibit the oxidation of low density lipoprotein (LDL), and further, they can be used as a component for medicine and food to effectively prevent and treat cardiovascular diseases such as hyperlipemia and arteriosclerosis.
REFERENCES:
patent: 1020010008884 (2001-02-01), None
patent: 2001069898 (2001-07-01), None
David L. Nelson, et al. Lehninger Principles in Biochemistry, lipid biosynthesis, 2000, 770-817.
Daniel Steinberg, et al., 3rd Edition, 2000 Worth Publishers, New York; N. Engl. J. Med., “Beyond Cholesterol, Modifications of Low-Density Lipoprotein That Increase Its Atherogenicity”, 1989, 320, 915-924.
Charles R. Cannan, et al. Circulation, American Heart Association, Natural History of Hypertrophic Cardiomyopathy, 1995, 92, 2488-2496.
Peter Wagner, et al. Arterioscler. Thromb. Vase. Biol., 1997, 17, “Copper Ions Promote Peroxidatin of Low Density Lipoprotein Lipid by Binding to Histidine Residues of Apolipoprotein B100, But They Are Reduced at Other Sites on LDL”, 3338-3346.
Masa-aki Kawashiri, et al., Curr. Atheroscler. Res., 2000, 2, High-Density Lipoprotein Metabolism; Molecular Targets for New Therapies for Atherosclerosis, pp. 363-363.
Eva Hurt Camejo, et al., “Phospholipase A2in Vascular Disease” Circ. Res. 2001, 89, 298-304.
Yun Seong Song, et al., “Anti-angiogenic, Antioxidant and Xanthine Oxidase Inhibition Activities of the Mushroom Phellinus Linteus”, J. Ethnopharmacol., 2003, 88, 113-116.
Eui-Il Hwang, et al., “Phellinsin A, a Novel Chitin Syunthases Inhibitor Produced byPhellinussp. PL3”, J. Antibiotcs., 2000, 9, 903-911.
Larsen and Cobb's group III, Synopsis Fungorum 3:Phellinus(Hymenochaetaecae)—A survey of the world taxa. p. 206, Fungiflora, Oslo, Norway, 1990.
Y. C. Dai and M. Q. Xu: Studies on the medicinal polypore,Phellinus baumii, and its kim, P. linteus, Mycotaxon 62, 191-200, 1998.
Ryuichi Mashima, et al. Curr Opin Lipidol., 2001, 12, 411-18.
Hwang Eui Il
Jeong Tae Sook
Kim Ju Ryoung
Kim Sung Uk
Lee Sang Han
Frommer & Lawrence & Haug LLP
Korea Research Institute of Bioscience and Biotechnology
Meller Michael V
Santucci Ronald R.
LandOfFree
Pharmaceutical composition and health food comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition and health food comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition and health food comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4230721